Kenall’s Indigo-Clean Technology Proven to Kill SARS-CoV-2
Industrial light fixture solutions company Kenall has announced that its Indigo-Clean technology has been proven in independent lab testing to safely kill 94 percent of viruses, including SARS-CoV-2 and Influenza-A. It can also kill harmful bacteria like Staph and MRSA with its LED lighting solution.
The Indigo-Clean product line uses visible light with a wavelength of 405nm to disinfect ambient air and nearby surfaces. In contrast to products that use ultraviolet light, there is a much lower risk of degrading materials or potentially harming people, offering a method of continuous disinfection in environments like schools, hospitals, medical centers, and more.
The Indigo-Clean series offers three kinds of disinfection products for a variety of applications. The Indigo-Clean EX has been proven to kill 99 percent of SARS-CoV-2 and also eliminates C. diff. The Dual-Mode Indigo-Clean solution offers blended white or indigo-only modes, proven to kill 94% of SARS-CoV-2 and Influenza-A when it runs at least 12 hours per day. And the single-mode Indigo-Clean series offers standard illumination and disinfection as long as the light is on.
“Indigo-Clean disinfection is in high demand and more critical than ever before,” said Dr. Cliff Yahnke, Director of Clinical Affairs for Indigo-Clean. “Confirming its ability to kill SARS-CoV-2 during this pandemic is a game-changer: It opens new possibilities from small congregate settings to locations that must, by necessity, host large groups of people. Now, instead of using more expensive, hazardous, and complicated technologies to kill viruses and bacteria, facility managers can simply install disinfection lighting and know that it is automatic and—more importantly—completely safe.”
Kenall was founded in 1963 in Chicago, Ill., and its products are designed in Kenosha, Wis., to comply with the Buy American Act.
About the Author
Matt Jones is senior editor of Spaces4Learning. He can be reached at [email protected].